ClinicalThought

Share

Program Content

Activities

  • <i>BRCA</i> Testing in EBC and Adjuvant PARP Inhibition
    Current Essential Testing in Early Breast Cancer: A Focus on BRCA Testing and Adjuvant PARP Inhibition
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

    Expires: November 16, 2023

    View Activity
  • Our Experiences With BRCA Testing and Adjuvant PARP Inhibition in EBC
    Our Experiences With the Expanded Role of BRCA Testing and Adjuvant PARP Inhibition in Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 05, 2023

    View Activity

Faculty

cover img faculity

Banu Arun, MD

Professor, Breast Medical Oncology
Co-Director, Clinical Cancer Genetics 
Executive Director, Cancer Genetics
MD Anderson Cancer Networks
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Charles E. Geyer, Jr., MD

Professor of Medicine
Division of Hematology/Medical Oncology
Department of Internal Medicine
University of Pittsburgh UPMC Hillman Cancer Center
Staff Attending
Breast Medical Oncology
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania

cover img faculity

Allison Butts, PharmD, BCOP

Pharmacist Manager, Oncology
Clinical Pharmacist, Breast Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
Assistant Adjunct Professor, UK College of Pharmacy
UK HealthCare
Lexington, Kentucky

cover img faculity

Marissa Marti-Smith, APRN, AGNP-C, AOCNP

Nurse Practitioner
Breast Oncology
Texas Oncology Baylor Sammons Cancer Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

ProCE

ProCE Banner